<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xml:base="http://www.kymos.com/en/blog" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"> <channel> <title></title> <link>http://www.kymos.com/en/blog</link> <description></description> <language>en</language> <atom:link href="http://www.kymos.com/en/blogs.xml" rel="self" type="application/rss+xml" /> <item> <title>Kymos approval as reference lab for biologics in Lebanon</title> <link>http://www.kymos.com/en/blog/kymos-approval-reference-lab-biologics-lebanon</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-approval-reference-lab-biologics-lebanon&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/lebanon.jpeg?itok=UZ-FEFjQ&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;The &lt;a href=&quot;https://www.moph.gov.lb/en&quot;&gt;Ministry of Public Health of the Republic of Lebanon&lt;/a&gt; has approved KYMOS as Reference Laboratory for Biological Drug Tests. This is an important acknowledgement to the efforts undertaken by KYMOS to develop innovative analytical methods for biosimilars and biotechnological products.&lt;/p&gt; &lt;p&gt;KYMOS has experience in method development, validation and testing of different biosimilars like infliximab, trastuzumab, pelgastrim or omalizumab; polisaccharides as heparins; immunoglobulins; insulines; and innovative antibody drug conjugates.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Fri, 02 Mar 2018 17:34:46 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">395 at http://www.kymos.com</guid> </item> <item> <title>New Cosmetics Regulation in Spain</title> <link>http://www.kymos.com/en/blog/new-cosmetics-regulation-spain</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/new-cosmetics-regulation-spain&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/cosmetics.jpg?itok=rrvDw5Ox&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;Cosmetics were widely regulated in the framework of the European Union through the &lt;a href=&quot;http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32014R1004&quot;&gt;Regulation (EC) No. 1223/2009 of the European Parliament and of the Council of November 30, 2009&lt;/a&gt; on cosmetic products. The aim of this regulation was: i) strengthened safety requirements, ii) introduction of “responsible person” position, iii) centralized notification of cosmetic products marketed in the EU, iv) reporting of serious undesirable effects.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Fri, 02 Mar 2018 17:10:57 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">394 at http://www.kymos.com</guid> </item> <item> <title>Fit-to-purpose bioanalytical methods: scientific validation</title> <link>http://www.kymos.com/en/blog/fit-purpose-bioanalytical-methods-scientific-validation</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/fit-purpose-bioanalytical-methods-scientific-validation&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/3xquad_6500plus_450x450.jpg?itok=Al9HdKJI&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;API 6500 Sciex&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;Over the past 25 years the criteria required for bioanalytical methods has evolved significantly. The harmonization of bioanalytical methods requirements started in 1990 during the AAPS and FDA Crystal City Meetings. In 2000 the Crystal City II Meeting laid the foundations of the 2001 FDA Guidance on Bioanalytical Method Validation.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Tue, 13 Feb 2018 10:46:27 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">390 at http://www.kymos.com</guid> </item> <item> <title>Putting our clients always first</title> <link>http://www.kymos.com/en/blog/putting-our-clients-always-first</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/putting-our-clients-always-first&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/snow.jpeg?itok=z6SPlMh2&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;Snow Kymos&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;div&gt;These first days of February, Northern Spanish regions have suffered very bad weather conditions. In Kymos we are always devoted to our clients and partners. We have not stopped our activity in the ground. Unfortunately this time the road was finally closed and we had to pospone the planned visits. We&#039;ll keep on trying!&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Thu, 08 Feb 2018 14:26:23 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">389 at http://www.kymos.com</guid> </item> <item> <title>Opening Event at Pharmaprogress laboratories</title> <link>http://www.kymos.com/en/blog/opening-event-pharmaprogress-laboratories</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/opening-event-pharmaprogress-laboratories&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/img_0766.jpg?itok=zjifHfM9&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;Pharmaprogress opening&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;On December 19, the Mayor of Camerata Picena Mr. Paolo Tittarelli, inagurated the refurbished facilities of Pharmaprogress in Ancona (Italy). An important investment plan has been executed after the Pharmaprogress acquisition by Kymos in November 2016. The refurbishement has been focused in electric supply lines, power generator, data center, LAN and laboratory benches. In addition, during this first year new HPLCs, balances, and other instruments have been acquired. The visit of the Mayor finished with a Christmas cellebration with employees and partners.&lt;/p&gt; &lt;p&gt; &lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Fri, 29 Dec 2017 09:38:28 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">376 at http://www.kymos.com</guid> </item> <item> <title>KYMOS communication in the 10th EBF Symposium</title> <link>http://www.kymos.com/en/blog/kymos-communication-10th-ebf-symposium</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-communication-10th-ebf-symposium&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/morte.jpeg?itok=ELYHgjOY&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;Immunogenicity study communication&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;Kymos presented an oral communication on the immunogenicity of gonadotrophines used for ovarian stimulation, during the 10th EBF Open Symposium held past 15-17 November 2017 in Barcelona. Kymos&#039; Immunology Manager, Dr. Carles Morte, shared with the attendees the bioanalytical strategy followed and the results of two clinical studies. This work was done in collaboration with IBSA (Switzerland), the University of Basel (Switzerland), the Semmelweis University (Budapest, Hungary) and the Institut Universitari Dexeus (Barcelona, Spain).&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://kymos.com/sites/default/files/presentation_ebf_v5.0.pdf&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Tue, 28 Nov 2017 22:21:20 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">371 at http://www.kymos.com</guid> </item> <item> <title>FDA recognizes 8 European Agencies for inspections </title> <link>http://www.kymos.com/en/blog/fda-recognizes-8-european-agencies-inspections</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/fda-recognizes-8-european-agencies-inspections&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/fda_.jpg?itok=zD8gbAwE&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;FDA logo&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;The U.S. Food and Drug Administration has determined the agency will recognize eight European drug regulatory authorities as capable of conducting inspections of manufacturing facilities that meet FDA requirements. The eight regulatory authorities found to be capable are those located in: Austria, Croatia, France, Italy, Malta, Spain, Sweden and the United Kingdom.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583057.htm&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Mon, 20 Nov 2017 08:04:49 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">370 at http://www.kymos.com</guid> </item> <item> <title>Kymos in the CPhI 2017 in Frankfurt</title> <link>http://www.kymos.com/en/blog/kymos-cphi-2017-frankfurt</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-cphi-2017-frankfurt&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/img_0220_0.jpg?itok=yjhH6oXo&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;Kymos stand at CPhI 2017 in Frankfurt&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;KYMOS and its Italian affiliate PHARMAPROGRESS have particIpated in the Worldwide CPhI 2017 in Frankfurt during October 24-26. The stand was very attended and we had around 80 meeting with current and potencial partners. We thank all our visitors for their interest and friendliness.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Mon, 30 Oct 2017 10:38:28 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">365 at http://www.kymos.com</guid> </item> <item> <title>CRO Market Growth</title> <link>http://www.kymos.com/en/blog/cro-market-growth</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/cro-market-growth&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/cro_market_0.jpg?itok=_kacQi4B&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;The global CRO market value is expected to exceed $32 billion in 2017 and reach $45 billion by 2022, according to a report by Grand View Research, with growth attributed to greater R&amp;amp;D spend, M&amp;amp;A activity, as well as government contracts with CROs. The role of CROs in helping pharma and biopharma firms address today’s complex drug development challenges, has grown considerably these past few years.&lt;/p&gt; &lt;p&gt; &lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Saturday, December 12, 2015 - 15:00&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Sun, 17 Sep 2017 08:25:11 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">360 at http://www.kymos.com</guid> </item> <item> <title>Kymos in the 5th Antibody Symposium 2017 in Tours, France</title> <link>http://www.kymos.com/en/blog/kymos-5th-antibody-symposium-2017-tours-france</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-5th-antibody-symposium-2017-tours-france&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/adc_symposium_2017_0.jpg?itok=6FG2mTNp&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;Kymos at 5th Antibody Industrial Symposium 2017&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;KYMOS participates with a booth in the 5th Antibody Industrial Symposium 2017, that takes place on June 27 and 28 in Tours, France. This year the scope of the Symposium is the Antibody-Drug Conjugates. An important pannel of experts presented the last innovations in this field and the new products that will be hopefully marketed in the years to come.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://ais2017.fr&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Wed, 28 Jun 2017 08:14:15 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">280 at http://www.kymos.com</guid> </item> <item> <title>Great Success of the &quot;Phase I Clinical Trials in Spain&quot;</title> <link>http://www.kymos.com/en/blog/great-success-phase-i-clinical-trials-spain</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/great-success-phase-i-clinical-trials-spain&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/img_0705.jpg?itok=FNSTqb_2&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;KYMOS and the IFTH&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;KYMOS is a proud to have been the sponsor and coorganizer of the &quot;Phase I Clinical Trials in Spain&quot; Session. The event took place on June 14 in the Barcelona Sicence Park and had a great success with around 100 attendees. KYMOS&#039; CEO, Joan Puig de Dou, welcomed and farewelled the participants. Other KYMOS team members participate during the event: Lluisa Garcia (COO) moderated a roundtable and Jaume Pascual (Scientific Director Small Molecules) and Carles Celma (Scientific Director Biologics) exhibited very interesting scientific presentations.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.kymos.com/sites/default/files/programa_-_links.html&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Sat, 17 Jun 2017 14:04:00 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">279 at http://www.kymos.com</guid> </item> <item> <title>Kymos in the 57 Simposium AFI at Rimini, June 7-9, 2017</title> <link>http://www.kymos.com/en/blog/kymos-57-simposium-afi-rimini-june-7-9-2017</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-57-simposium-afi-rimini-june-7-9-2017&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/2017-06-07_15.31.47.jpg?itok=ngDTboCE&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;Kymos at Rimini&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;KYMOS participates in the yearly conference of the Italian Association of Industry Pharmacists (AFI) in Rimini. KYMOS and its Italian affiliate PHARMAPROGRESS take up the stand #8 showing up its analytical capabilities in small molecules and biologics.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.afiscientifica.it/oggetti.php?user=&amp;amp;pwd=&amp;amp;id=309&amp;amp;operazione=&amp;amp;page_name=&amp;amp;id_tipo=L&amp;amp;id_padre=0&amp;amp;id_oggtipo=0&amp;amp;filtro=&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Thu, 08 Jun 2017 05:54:37 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">276 at http://www.kymos.com</guid> </item> <item> <title>Kymos coordination of ICH Q3D course in the framework of IL3 UB program</title> <link>http://www.kymos.com/en/blog/kymos-coordination-ich-q3d-course-framework-il3-ub-program</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-coordination-ich-q3d-course-framework-il3-ub-program&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/taula_periodica.jpg?itok=HEQcBR8u&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;Periodic table&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;Jaume Pascual, Scientifc Director of Kymos, coordinated a course of IL3 (Barcelona University) about the guideline ICH Q3D on Elemental Impurities. The course took place at Barcelona, the last 1st of June with a lot of success and more of 75 attendants.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.il3.ub.edu/farmacia/aproximacion-practica-implementacion-directiva-ich-q3d.html&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Sun, 04 Jun 2017 17:22:33 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">273 at http://www.kymos.com</guid> </item> <item> <title>Revisions of Medical Device Directives</title> <link>http://www.kymos.com/en/blog/revisions-medical-device-directives</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/revisions-medical-device-directives&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/med_dev.png?itok=EXKo8Y89&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;On 5 April, the European Parliament and the Council are adopted two new Regulations on medical devices: &lt;a href=&quot;http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2017:117:TOC&quot; style=&quot;box-sizing: border-box; background-color: transparent; color: rgb(85, 26, 139);&quot;&gt;Regulation (EU) 2017/745&lt;/a&gt; on medical devices and &lt;a href=&quot;http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2017:117:TOC&quot; style=&quot;color: rgb(85, 26, 139); box-sizing: border-box; background-color: transparent;&quot;&gt;Regulation (EU) 2017/746&lt;/a&gt; on in vitro diagnostic medical devices. The new rules will only apply after a &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://ec.europa.eu/growth/sectors/medical-devices/regulatory-framework/revision_en&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Tue, 09 May 2017 21:24:03 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">265 at http://www.kymos.com</guid> </item> <item> <title>Scientific Session: Phase I Clinical Trials in Spain</title> <link>http://www.kymos.com/en/blog/scientific-session-phase-i-clinical-trials-spain</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/scientific-session-phase-i-clinical-trials-spain&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/jornada_ec.jpeg?itok=i7GxBrcO&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;KYMOS is a proud sponsor and coorganizer of the Scientific Session on Phase I Clinical Trials in Spain, that will take place on June 14 in the Barcelona Sicence Park. KYMOS&#039; CEO, Joan Puig de Dou, will welcome the atendants to this event and KYMOS&#039; COO, Lluisa Garcia, will moderate a roundtable during the event.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.ifth.es/congresos-y-redes/jornada-eecc-fase-i/ii-jornada-eecc-fase-i/&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Fri, 05 May 2017 09:11:42 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">264 at http://www.kymos.com</guid> </item> <item> <title>EMA&#039;s new Guideline on the Implementation of the ICH Q3D</title> <link>http://www.kymos.com/en/blog/emas-new-guideline-implementation-ich-q3d</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/emas-new-guideline-implementation-ich-q3d&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/dscf8033.jpg?itok=LeLCca-I&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;ICP-MS Agilent&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;On 8 March 2017, the EMA published the guideline &quot;Implementation strategy of ICH Q3D&quot;. The final version contains notable changes: (i) analytical methods have to be validated for the intended purpose, (ii) a summary of the risk assessment has to be submitted in the marketing authorisation dossier, (iii) If limited knowledge of the possible sources routine testing for all elements has to be performed, and (iv) both approaches &quot;Drug Product Approach&quot; and &quot;Component Approach&quot; are accepted.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.gmp-compliance.org/gmp-news/emas-new-guideline-on-the-implementation-of-the-ich-q3d-guideline-in-the-eu&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Sat, 08 Apr 2017 13:59:34 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">262 at http://www.kymos.com</guid> </item> <item> <title>EMA Suspends Drugs Associated with Micro Therapeutic Research Labs</title> <link>http://www.kymos.com/en/blog/ema-suspends-drugs-associated-micro-therapeutic-research-labs</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/ema-suspends-drugs-associated-micro-therapeutic-research-labs&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/micro.jpeg?itok=o-4SI6a_&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;The European Medicines Agency (EMA) announced on March 24, 2017 that it was recommending the suspension of approved drugs and delaying the approval of drugs under review for which bioequivalence studies were conducted by Micro Therapeutic Research Labs. The suspension is because the agency has determined that the bioequivalence data produced by Micro Therapeutic Research Labs is unreliable.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.pharmtech.com/ema-suspends-drugs-associated-micro-therapeutic-research-labs-0&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Tue, 28 Mar 2017 15:47:22 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">260 at http://www.kymos.com</guid> </item> <item> <title>KYMOS renews its cooperation agreement with Ipsen</title> <link>http://www.kymos.com/en/blog/kymos-renews-its-cooperation-agreement-ipsen</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-renews-its-cooperation-agreement-ipsen&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/ipsen_joan_luisa_0.jpg?itok=YOT2qBl8&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;KYMOS signed the renewal of the already existing strategic agreement with the multi-national pharmaceutical company on 29 November last. This signature means the extension of the contract for the next 5 years, and ensures significant volumes of work within the field of biotechnological research.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Wednesday, December 7, 2016 - 09:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.ipsen.com/&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Thu, 08 Dec 2016 15:14:43 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">251 at http://www.kymos.com</guid> </item> <item> <title>KYMOS acquires Italian firm Pharmaprogress</title> <link>http://www.kymos.com/en/blog/kymos-acquires-italian-firm-pharmaprogress</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-acquires-italian-firm-pharmaprogress&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/foto_ph_web.png?itok=wHMIBiQ4&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;The company, founded in 2001, has accelerated its international expansion plan. With this purchase, 50% of its business volume will be generated outside of Spain.&lt;br /&gt; Pharmaprogress, located in the city of Ancona, specialises in contract research and analysis services and expects to post turnover of €1 million in 2017.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Saturday, December 12, 2015 - 15:00&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.lavanguardia.com/vida/20161117/411938749537/kymos-adquiere-la-italiana-pharmaprogress.html&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Thu, 17 Nov 2016 12:12:10 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">247 at http://www.kymos.com</guid> </item> <item> <title>Kymos is present in CPhI Worldwide from 4th to 6th of October in Barcelona</title> <link>http://www.kymos.com/en/blog/kymos-present-cphi-worldwide-4th-6th-october-barcelona</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-present-cphi-worldwide-4th-6th-october-barcelona&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/img_6988.jpg?itok=gfDB6tuS&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;For the first time Kymos will be present in CPhI Worldwide 2016 with an own stand located in the 7th Hall, number 7D73. This important event will take place from 4th to 6th of October in Barcelona. Kymos will share the exhibition area with two partner companies, Mitelos and Asphalion.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Saturday, December 12, 2015 - 15:00&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.cphibarcelona.b-network.com/Close.aspx&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Mon, 03 Oct 2016 14:14:37 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">245 at http://www.kymos.com</guid> </item> <item> <title>Hundreds of drugs may be suspended in EU after flawed tests</title> <link>http://www.kymos.com/en/blog/hundreds-drugs-may-be-suspended-eu-after-flawed-tests</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/hundreds-drugs-may-be-suspended-eu-after-flawed-tests&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/semler.jpg?itok=dhGozw_I&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;The European Medicines Agency called for a halt to sales of hundreds of medicines that were tested in India, after an inspection of the research site found “substitution and manipulation” of study samples.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Saturday, December 12, 2015 - 15:00&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.bloomberg.com/news/articles/2016-07-22/flawed-indian-studies-spur-eu-regulator-to-back-drug-suspensions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Mon, 01 Aug 2016 15:43:04 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">237 at http://www.kymos.com</guid> </item> <item> <title>Kymos in the Press</title> <link>http://www.kymos.com/en/blog/kymos-press</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/kymos-press&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/kymos_team.png?itok=kCN9c9Ry&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;Kymos appeared in the Press last 24th of June in the economy section of the Spanish newspaper La Vanguardia. The journalist explained the evolution of the company from its beginnings, the actual figures and its future expectations. The press article included a photo of the management team. Click below for access to the full content.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Saturday, December 12, 2015 - 15:00&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.lavanguardia.com/economia/20160624/402721108511/kymos-biotec.html&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Tue, 28 Jun 2016 12:45:54 +0000</pubDate> <dc:creator>kymos</dc:creator> <guid isPermaLink="false">228 at http://www.kymos.com</guid> </item> <item> <title>New Clinical Trials Regulation in Europe</title> <link>http://www.kymos.com/en/blog/new-clinical-trials-regulation-europe</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/new-clinical-trials-regulation-europe&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/UE%20map.jpg?itok=zM2FOEZ-&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;A new Regulation of the European Parliament and of The Council on Clinical Trials on Medicinal Products for Human Use, directly applies to all individuals in the European Union. It was adopted by the European Parliament (02 April 2014) and by the Council of Ministers (14 April 2014) and signed off on 16 April 2014. It was published in the Official Journal on 27 May 2014 and is expected to become effective on 15 June 2016.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Saturday, December 12, 2015 - 15:00&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://ec.europa.eu/health/human-use/clinical-trials/index_en.htm&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Wed, 30 Mar 2016 13:43:29 +0000</pubDate> <dc:creator>admin</dc:creator> <guid isPermaLink="false">1 at http://www.kymos.com</guid> </item> <item> <title>CataloniaBio Gala Dinner 2016</title> <link>http://www.kymos.com/en/blog/cataloniabio-gala-dinner-2016</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/cataloniabio-gala-dinner-2016&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/Junta%20CataloniaBio.png?itok=_7Cp7zNI&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;CataloniaBio board&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;On March 10, Pedralbes Palace in Barcelona hosted the CataloniaBio Gala Dinner 2016. CataloniaBio is an association of companies committed with research, development and innovation in biosciences. The association cellebrated the 10th Anniversary. Joan Puig de Dou, KYMOS CEO and member of the CataloniaBio Association&#039;s Board, attended this event accompanied by other KYMOS team members. The dinner was presided over by Catalan Minister of Health, Antoni Comín, and Catalan Minister of Business and Knowledge, Jordi Baiget.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Monday, October 3, 2016 - 13:15&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://cataloniabio.org/ca/ignasi-biosca-els-inversors-estan-corroborant-el-comprom%C3%ADs-amb-el-sector&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Thu, 10 Mar 2016 12:10:11 +0000</pubDate> <dc:creator>admin</dc:creator> <guid isPermaLink="false">109 at http://www.kymos.com</guid> </item> <item> <title>Innovative SME Stamp</title> <link>http://www.kymos.com/en/blog/innovative-sme-stamp</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/innovative-sme-stamp&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/Innovative%20SME.png?itok=uE3cVm-l&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;Kymos has been successfully awarded by the Innovative SME stamp (PYME Innovadora), provided by the Spanish Ministry of Economy. It allows the company to obtain financial benefits as it deals with a wide range of analytical projects within the R+D+i areas. In addition to that, Kymos is also proud to hold the CIR certificate (Crédit Impôt Recherche) valid for the period 2015-2017 granted by the French Ministry of Higher Education and Research.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Tuesday, December 15, 2015 - 15:00&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.6f2062042f6a5bc43b3f6810d14041a0/?vgnextoid=45cc94d74dd4a410VgnVCM1000001d04140aRCRD&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Mon, 18 Jan 2016 04:12:36 +0000</pubDate> <dc:creator>admin</dc:creator> <guid isPermaLink="false">4 at http://www.kymos.com</guid> </item> <item> <title>Grand opening party for new KYMOS laboratories</title> <link>http://www.kymos.com/en/blog/grand-opening-party-new-kymos-laboratories</link> <description>&lt;div class=&quot;field field-name-field-image field-type-image field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;a href=&quot;/en/blog/grand-opening-party-new-kymos-laboratories&quot;&gt;&lt;img src=&quot;http://www.kymos.com/sites/default/files/styles/blog_list_panoramic/public/field/image/carpa%20inauguracion.jpg?itok=fsYWXEYf&quot; width=&quot;825&quot; height=&quot;350&quot; alt=&quot;&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;p&gt;The company has invested 2 million Euros in state-of-the-art technology with the aim to expand its R&amp;amp;D and Quality Control services addressed to the biopharmaceutical industry. The new headquarters takes up an area of 1,500 sq.m. at the Parc Tecnològic del Vallès (Barcelona). Kymos is going ahead with its internationalisation projects and expects a yearly growth of 20% for the following years.&lt;/p&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-date field-type-datetime field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Date:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;&lt;span class=&quot;date-display-single&quot;&gt;Monday, December 7, 2015 - 15:00&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-link field-type-text field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Enlace leer mas:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot;&gt;http://www.pmfarma.es/noticias/20863-el-presidente-de-la-generalitat-inaugura-los-nuevos-laboratorios-de-kymos.html&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description> <pubDate>Fri, 05 Jun 2015 08:26:59 +0000</pubDate> <dc:creator>admin</dc:creator> <guid isPermaLink="false">2 at http://www.kymos.com</guid> </item> </channel> </rss>